0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Reports |

Interferon- 2b: A New Treatment for Polycythemia Vera

Richard T. Silver, MD
[+] Article and Author Information

From the New York Hospital-Cornell Medical Center, New York, New York. Requests for Reprints: Richard T. Silver, MD, Section of Clinical Oncology Chemotherapy Research, New York Hospital-Cornell Medical Center, 525 East 68 Street, Box 581, New York, NY 10021. Acknowledgments: The author thanks Helen Zurawinsky, BS, for administrative assistance, Audrey Gutfriend, BS, RN, for patient care responsibilities, and Arthur Sawitsky, MD, and Ted P. Szatrowski, MD, PhD, for review of the manuscript. Grant Support: In part by grants from the United Leukemia Fund and Cancer Research and Treatment Fund, Inc. No funds for this study were requested or provided by Schering Corporation, the manufacturer of recombinant interferon- 2b (Intron-A). However, three patients have been supplied with Intron-A on a compassionate basis at my request.


Copyright 2004 by the American College of Physicians


Ann Intern Med. 1993;119(11):1091-1092. doi:10.7326/0003-4819-119-11-199312010-00006
Text Size: A A A

Polycythemia vera is characterized by an increased red cell mass and thrombohemorrhagic complications. In general, treatment has consisted of phlebotomy to reduce the red cell mass. However, because treatment with phlebotomy only is associated with early, frequently fatal thrombosis or hemorrhage [1], myelosuppressive therapy is also used. Unfortunately, the agents used, chlorambucil and radioactive phosphorus, are leukemogenic [1].

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)